Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
Date:3/7/2013


5,304  Interest receivable327363  Amounts receivable714449  Prepaid and other current assets3,7551,210  Property, equipment and other assets1,523689Total assets$
82,016$
8,015Liabilities and stockholders' equity:  Accounts payable and accrued liabilities$
7,050$
3,217  Deferred collaboration revenue-18,271  Current portion of long-term obligations1,0841,417  Warrant liability3,4227,881  Long term liabilities4,2536,339  Stockholders' equity66,20730,890Total liabilities and stockholders' equity$
82,016$
8,015 

Conference Call Details OncoGenex will host a conference call at 4:30 p.m. Eastern Time today, Thursday, March 7, 2013, to provide a business update and discuss the fourth quarter and year end 2012 results.

A live event will be available on the Investor Relations section of the OncoGenex Web site at www.OncoGenex.com. Alternatively, you may access the live conference call by dialing 877-606-1416 (U.S. & Canada) or 707-287-9313 (International). A replay of the webcast will be available approximately two hours after the call and will be archived for 90 days.

ABOUT ONCOGENEX
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. (NYSE:  TEVA) have entered a global collaboration and license agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresecta
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
2. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
3. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
4. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
5. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
7. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
9. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
10. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
11. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015   Intarcia Therapeutics, Inc. ... Brady as Vice President, Human Resources, reporting directly ... CEO. As a new key member of the senior ... CEO and Leadership Team to assure the Company advances ... further embeds its core values and its dynamic culture. ...
(Date:5/1/2015)... , May 01, 2015 Research and Markets ... "Asian Dermatology Devices Market by Type, by End User - ... The Asian Dermatology Devices market is estimated to grow at ... China holds a larger share in the Dermatology ... Japan . The Asian Dermatology Devices market holds a ...
(Date:5/1/2015)... ATLANTA , May 1, 2015 At ... May 2-6 in Washington D.C. , ... a solution that enables clinicians to leverage the enormous ... Knife radiosurgery treatments conducted each year – to advance ... "Gamma Knife Registry is a cloud-based solution that allows ...
Breaking Medicine Technology:Intarcia Appoints James P. Brady Vice President, Human Resources 2Intarcia Appoints James P. Brady Vice President, Human Resources 3Intarcia Appoints James P. Brady Vice President, Human Resources 4Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3
...  April 18, 2011 Bedford Laboratories™, a division ... announce the addition of Topotecan Hydrochloride for Injection, ... is AP Bioequivalent to the reference listed drug ... GlaxoSmithKline. Topotecan Hydrochloride for Injection is indicated for ...
... Corporation (Nasdaq: LMNX ) today announced that it ... on Monday, May 9, 2011. A press release announcing the ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management ... and financial results for the first quarter ended March 31, ...
Cached Medicine Technology:Bedford Laboratories™ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 3
(Date:5/2/2015)... 02, 2015 With the success that Veatch ... proud to welcome Neida Miranda and Alex Shields to the ... has over 41 years of combined experience working with dentists ... the dental field for 8 years. She was certified ... Texas. Customer service, positive attitude and showing the importance of ...
(Date:5/1/2015)... Turks and Caicos Islands, BWI (PRWEB) May 02, 2015 ... a new website! It is http://www.thevenetiangracebay.com , ... itself, and it incorporates the stunning white and attractive ... to a study of Google, sixty seven percent of ... The study showed that smartphones were used in ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 Jusuru ... Award for the successful repositioning of its flagship nutritional ... company brand with a new name, new logo, new ... DSA Ethos Awards are designed to identify and promote ... its best. , “DSA congratulates Jusuru International for ...
(Date:5/1/2015)... Va. (PRWEB) May 01, 2015 The ... nation’s leading nonprofit authority on the use of health ... as a key contributing resource to the United States ... use of electronically readable cards in Medicare. The report, ... and Providers ” was released to the public on ...
(Date:5/1/2015)... 01, 2015 It’s raining bills on Capitol ... proposals to expand federal support for telemedicine. , ... has been working with Congress,” said Jonathan Linkous, CEO of ... the nation is poised to embrace the use of telecommunications ... step in fulfilling ATA’s mission to improve quality, access, equity ...
Breaking Medicine News(10 mins):Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... as an injection into the brain of mice, study finds ... further insight into how a health-boosting compound found in red ... , But scientists have only seen the effect in mice ... emerged that consuming red wine or other products made with ...
... diseases, most health professionals do not have access to ... earliest and most infectious stage. A recent survey ... of syphilis appears in the November 15, 2009 issue ... Definitive diagnosis of primary syphilis (the earliest stage ...
... Delhi, Singapore and Washington DC (October 22, 2009) The rates ... 12 are no higher during the Halloween season than at ... published in the September issue of Sexual Abuse: A ... the Association for the Treatment of Sexual Abusers (published by ...
... Studies by researchers at Wake Forest University School ... in immature rats leads to profound, rapid brain injury ... The N-methyl-D-aspartate (NMDA) receptor is activated when ... by brain cells. This allows calcium to enter into ...
... ARBOR, Mich.---Someone healthy enough to work could still cost an ... A new University of Michigan study shows workers ... employers up to $5,867 annually in health care, pharmacy and ... the good news: Companies can stop those chronic health problems ...
... have best chance of success , THURSDAY, Oct. 22 (HealthDay ... which ones offer the best chance of success with in ... process of selecting embryos for implantation in the mother,s womb ... end in IVF failure or multiple pregnancies," Dr. Emre Seli, ...
Cached Medicine News:Health News:Red-Grape Compound May Improve Diabetes 2Health News:Halloween sex offender policies questioned 2Health News:General anesthetics lead to learning disabilities in animal models 2Health News:General anesthetics lead to learning disabilities in animal models 3Health News:Extra care for outwardly healthy workers costs companies millions annually 2Health News:Assessing Embryo Metabolism May Aid IVF Success 2
... Horizon Cardiology Hemo is a comprehensive ... for the cath lab. Patient ... cardiac images and procedural information all ... patient record, eliminating repetitive data entry. ...
... is a patient monitoring system providing real-time ... at the tissue level, reflecting the patients ... low power light and detects light that ... light is guided to the tissue by ...
PowerMed is a billing software....
Protologics Corporation announces ProtoCLAIMS, Web-based electronic claims product that links and reconciles desktop claims with insurance payers who offer direct claims processing....
Medicine Products: